首页> Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA> Site-specific differential effects of once-yearly zoledronic acid on the hip assessed with quantitative computed tomography: Results from the HORIZON Pivotal Fracture Trial

Site-specific differential effects of once-yearly zoledronic acid on the hip assessed with quantitative computed tomography: Results from the HORIZON Pivotal Fracture Trial

导出原文传递

翻译打印收藏纠错

第一作者： Yang,L.

作者： Yang,L. ^[1] ; Sycheva,A.V. ^[2] ; Black,D.M. ; Eastell,R.

作者单位： Academic Unit of Bone Metabolism, University of Sheffield, Sheffield S10 2RX, United Kingdom ^[1] Department of Epidemiology and Biostatistics, University of California, San Francisco CA, United ^[2]

关键词 Bisphosphonates Bone QCT Osteoporosis Volumetric BMD Zoledronic acid

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Osteoporosis international

2013年24卷1期

329-338页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Osteoporosis international

2013年24卷1期

329-338页

检索历史清除

Site-specific differential effects of once-yearly zoledronic acid on the hip assessed with quantitative computed tomography: Results from the HORIZON Pivotal Fracture Trial

Osteoporosis international

相似文献

同项目论文

Osteoporosis international

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Site-specific differential effects of once-yearly zoledronic acid on the hip assessed with quantitative computed tomography: Results from the HORIZON Pivotal Fracture Trial

Osteoporosis international

相似文献

同项目论文

Osteoporosis international

相关期刊

检索历史清除